Skip to main content
. 2021 Oct 28;13(11):1806. doi: 10.3390/pharmaceutics13111806

Table 2.

Clay minerals in 3DP technology with potential applications in medicine and TE.

Clay Mineral and Concentration Other Ink Ingredients Clay Role 3DP Technique Ref
MMT (Cloisite® 30B)—4% w/w PLA Increasing PLA crystallinity, melting temperature modifier and mechanical reinforcement Fused deposition modelling [21,22]
MMT (Cloisite® 5, Cloisite® 20, Na Cloisite®)—1, 5% w/w PLA Improved mechanical properties of PLA by organo-modified clay minerals due to increased d-spacing of organo-modified clay particles Fused filament fabrication [25]
MMT—0.5, 1, 2, 5% w/w HDPE MMT provided superior mechanical performance Fused filament fabrication [20]
MMT (Cloisite® SE300)—1, 3, 5% w/w PETG Mechanical reinforcement. Simplification of the 3D construct post-processing or post-treatment Extrusion [26]
SEP—1, 2, 3, 5, 7% w/w PETG Improvement of mechanical properties due to directional alignment of SEP particles within PETG filament Fused deposition modelling [27]
LAP—2.5% w/v Silk fibroin Formation of a print-bed (in combination with PEG) to support silk-fibroin BI 3D constructs Submerged extrusion into LAP–PEG suspension [28]
LAP—7% w/w NIPAAM, PAAM Rheological modifier for 3DP and mechanical reinforcement Extrusion [29]
LAP—12% w/v Pluronic Improvement of printability and mechanical properties of ink used as sacrificial material template (mold) for the production of microfluidic system Extrusion [30]